SCLERO.ORG
Search
SCLERO.ORG is retiring 4-24-2021. Thank you for the memories! You'll still find us in the Wayback Machine, and we'll carry your stories in our hearts forever.
Scleroderma Newsroom
ISN News Manager: Jo Frowde
Autoimmune
Media Stories
Scleroderma
ISN/Website
Autoimmune Archive
We maintain news archives for the most recent 3 years.
2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 - 2020 - 2019 - 2018

February 2018 Autoimmune News

Daily Fluctuations of Progesterone and Testosterone are Associated with Fibromyalgia Pain Severity. These results suggest that progesterone and testosterone play a protective role in fibromyalgia pain severity and other hormones may serve to both increase and decrease fibromyalgia pain severity. PubMed, J Pain, 12/14/2017. (Also see Fibromyalgia)

Diabetes: New pathway to treatment suggested by protein culprit. New research shows that a protein related to the development of anxiety and depression may also play a role in triggering diabetes. Medical News Today, 12/18/2017. (Also see Causes of Diabetes)

Quantifying the Effect of Diabetes on Surgical Hand and Forearm Infections. Diabetes exacerbates the burden of surgical upper–extremity infections and higher risk for amputation. PubMed, J Hand Surg Am, 12/11/2017. (Also see Symptoms and Complications of Diabetes)

Scoring hypoechogenic areas in one parotid and one submandibular gland increases feasibility of ultrasound in primary Sjögren's syndrome. Ultrasound examination of the parotid and submandibular glands on one side is sufficient to predict classification of patients according to the ACR–EULAR criteria. PubMed, Ann Rheum Dis, 12/11/2017. (Also see Diagnosis of Sjögren's Syndrome)

Rheumatic diseases are associated with a higher risk of dementia: A nation–wide, population–based, case–control study. In this population–based case–control study, we found that patients with rheumatic diseases are significantly associated with a higher risk of dementia. PubMed, Int J Rheum Dis, 12/15/2017. (Also see Systemic Autoimmune Rheumatic Diseases)

The risk of malignancy and its incidence in early rheumatoid arthritis (RA) patients treated with biologic DMARDs. In early RA patients, bDMARD use decreases the overall risk of developing malignancies; however, it does not affect the risk of developing hematologic malignancies. PubMed, Arthritis Res Ther, 2017 Dec 15;19(1):277. (Also see DMARDs and Treatments for Rheumatoid Arthritis)

Endothelial dysfunction in early systemic lupus erythematosus patients and controls without previous cardiovascular events. A high rate of endothelial dysfunction and vascular stiffness occurs in early lupus patients without cardiovascular risk factors and disease. PubMed, Arthritis Care Res (Hoboken), 12/15/2017. (Also see Symptoms and Complications of Lupus)

Cerebrovascular Events (CerVEs) in Systemic Lupus Erythematosus (SLE). CerVEs, the fourth most frequent neuropsychiatric event in SLE, are usually attributable to lupus. PubMed, Arthritis Care Res (Hoboken), 01/05/2018. (Also see Symptoms and Complications of Lupus)

How does stress make us ill? Study sheds light. Researchers at Michigan State University in East Lansing have revealed how a protein known as corticotropin–releasing factor receptor subtype 1 (CRF1) responds to stress by sending signals to specific immune cells. Medical News Today, 01/11/2017. (Also see Stress)

Metabolic syndrome (MetS) in psoriatic arthritis (PsA): the interplay with cutaneous involvement. Evidences from literature and a recent cross–sectional study. In our study, the occurrence of MetS and mean levels of serum uric acid were higher in PsA patients with clinical evident psoriasis compared to sine psoriasis PsA. PubMed, Clin Rheumatol, 01/08/2018. (Also see Psoriasis and Psoriatic Arthritis)

Go to Autoimmune News: January 2018
 

SCLERO.ORG was the world's leading nonprofit for trustworthy research, support, education and awareness for scleroderma and related illnesses from 1998 to 2021. It was a grassroots movement from the original Scleroderma from A to Z web site, which was founded by Shelley Ensz. We were a 501(c)(3) U.S.-based public charitable foundation. We closed this web site and our nonprofit agency in April 2021.

International Scleroderma Network (ISN)